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Suppl. Figure 1 | p110D gene targeting. The targeting approach to create the p110DD933A allele was 
similar to the strategy previously used for the creation of the p110GD910A allele (Okkenhaug et al. 
(2002), Science 297, 1031). Cloned genomic DNA covering the last 4 exons of the coding region of 
the p110D gene, Pik3ca, was isolated from a 129/Ola library. A point mutation, resulting in the DFG to 
AFG conversion of the conserved DFG motif in the C-terminal p110D kinase domain, was introduced 
by site-directed mutagenesis. Three additional features were incorporated into the targeting vector 
using standard restriction enzyme and PCR-based cloning techniques: (1) a silent mutation introducing 
a diagnostic MlsI restriction site in the third codon of the AFG motif, (2) a sequence encoding a C-
terminal Myc-epitope tag introduced immediately preceding the translational stop codon (to allow for 
recognition of the mutated protein with epitope-specific antibodies), and (3) a reporter/selection 
cassette flanked by loxP sites, inserted into the 3’ UTR sequence. The reporter/selection cassette 
contains an IRES sequence followed by the E-galactosidase (lacZ) coding sequence and a neomycin 
resistance gene expressed from its own promoter (MC1neopA). Vector-derived EcoRI and BamHI
sites between the Myc tag and the first loxP site were exploited for Southern blot analysis, as detailed 
below.
The linearized targeting construct was transfected into E14Tg2a (129/Ola strain) embryonic stem cells. 
Subsequently, G418-resistant clones with targeted integration of the vector were identified by 
Southern blot analysis of EcoRI- or BamHI-digested genomic DNA using probes (T3-ma12 and ma30-
T7, respectively) homologous to genomic sequence flanking and external to the vector homology 
arms. The presence of the AFG-encoding mutation was confirmed by DNA sequencing. Male chimeras
generated from clones with the AFG-encoding mutation were bred with C57BL/6 females and 
germline transmission confirmed by Southern blot analysis of tail DNA. Deletion of the selection 
cassette was achieved by intercrossing p110DD933A/WT mice with transgenic mice expressing Cre-
recombinase in the germline (Schwenk et al. (1995), Nucleic Acids Res 23, 5080) and verified by PCR 
analysis.
a, Organization of the p110D (PIK3CA) gene locus. DFG represents the conserved amino acid motif in 
the C-terminal p110D kinase domain. b, Linearized p110D targeting vector showing the AFG-
encoding mutation. c, Targeted p110D allele. d, Targeted p110D allele after Cre recombinase-mediated 
deletion of the reporter/selection cassette. e, Southern blot analysis using 5’ (T3-ma12) and 3’ (ma30-
T7) flanking probes of EcoRI- or BamHI-digested genomic DNA from tails of WT or p110DD933A/WT
mice still containing the reporter/selection cassette. f, g, PCR analysis of targeted alleles. Lane 1, WT
allele: the ma36-ma47 primer set amplifies a 574 bp fragment. Lanes 2 and 3, targeted allele before 
excision of selection cassette: the ma36-ma37 primer set fails to amplify a >12 kb fragment containing 
the selection cassette (or even if produced, the large size of the amplification product would preclude 
penetration of the gel). Inclusion of the NeoF2 primer, however, allows amplification of a 689 bp
product with the ma47 primer, revealing the presence of the selection cassette. Lane 4, targeted allele 
following Cre-mediated deletion of the selection cassette: the ma36-ma47 primer set amplifies a 
fragment of 753 bp, which includes DNA sequences encoding the Myc tag and one loxP site that was 
retained following Cre-mediated deletion of the selection cassette. Lane 5, inclusion of NeoF2 primer 
to the ma35-ma47 primer mix shows no difference from lane 4. * designates a PCR product 
corresponding to heteroduplexes of DNA of the WT and KI allele generated during PCR amplification, 
as revealed by DNA sequencing (data not shown) and further confirmed by alkaline agarose gel 
electrophoresis (shown in panel (g)).
Keys: Exon sequences are represented by filled black rectangles, intron sequences by a black line. 
Restriction sites are E (EcoRI), B (BamHI), M (MlsI). The relevant restriction fragments are 
highlighted by a dashed line with double arrows. Probe fragments are represented by gray lines. The 
Myc tag is shown as a filled blue rectangle, the loxP sites as red triangles with the pointed end 
indicating orientation and the loxP flanked IRES/lacZ/MC1neopA cassette components as yellow, 
orange and green filled rectangles, respectively. The positions of the primers used for PCR screening 
are designated by red arrows. The sequences of the primers are as follows: 
ma36: 5'-CCTAAGCCCTTAAAGCCTTAC-3', 
ma47: 5'-ACTGCCATGCAGTGGAGAAGCC-3', 
NeoF2: 5'-CTGTCATCTCACCTTGCTCC-3' 2
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Suppl. Figure 2 | a, Mouth-to-anus length of 6-week old p110DD933A/WT mice and WT 
littermates. b, Lean mass of p110DD933A/WT mice (n=11) and WT littermates (n=11) was 
determined by DEXA analysis and expressed as % of total body mass. c, Gastrocnemius muscle 
weights from 12 week old male mice (n=6 per genotype). Filled bars, WT mice; open bars, 
p110DD933A/WT mice.
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Suppl. Figure 3 | Weight of visceral organs in WT and p110DD933A/WT mice. A cohort of female 
p110DD933A/WT mice and WT littermates (n=5 per genotype) were weighed (left panel), then 
sacrificed and the indicated organs isolated and weighed (middle and right panel). Filled bars, 
WT mice; open bars, p110DD933A/WT mice. Values are mean r sem.
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Suppl. Figure 4, Foukas et al.
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Suppl. Figure 4 | a, Insulin tolerance test in male p110DD933A/WT (n=10) and WT (n=11) 
littermate mice. Calculated areas under the curves are shown. b, Morphometric analysis of 
pancreatic islets from WT and p110DD933A/WT mice. Pancreata were isolated from 11-12 week 
old male mice (n=6 per genotype). The tissues were fixed, processed for histology and analyzed 
as described in Methods. c, Glucose tolerance test in male p110DD933A/WT (n=18) and WT (n=19) 
littermate mice. Calculated areas under the curves are shown. d, Morphometric analysis of white 
adipose tissue from WT and p110DD933A/WT mice. Epididymal fat pads were isolated from 11-12 
week old male mice (n=6 per genotype). The tissues were fixed, processed for histology and 
analyzed as described in Methods. Solid lines/filled bars, WT mice; dashed lines/open bars, 
p110DD933A/WT mice. Values are mean r sem.
4
Supplementary Methods
Protein extraction, immunoprecipitation and immunoblotting. Tissues were removed, snap-frozen 
in liquid nitrogen and homogenized in a mortar with a pestle in lysis buffer (50 mM Tris.HCl pH 7.4, 5 
mM EDTA, 150 mM NaCl, 50 mM NaF and 1% Triton X-100 supplemented with 2 mg/ml aprotinin, 1 
mM pepstatin, 1 ng/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride and 1 mM sodium 
orthovanadate). Homogenates were clarified by centrifugation in a microcentrifuge. Supernatants were 
either analyzed directly or immunoprecipitated for 1 h with the indicated antibodies. Immune complexes 
were collected with 20 μl of 50% slurry of protein A- or protein G-Sepharose, washed with lysis buffer, 
resolved on 8% SDS-PAGE, and transferred onto PVDF membranes. The blots were probed with the 
indicated antibodies. Detection was performed by enhanced chemiluminescence (ECL, Amersham
Biosciences).
PI3K assay. Lipid kinase assays were performed essentially as described before (Vanhaesebroeck et al. 
(1997), Proc. Natl. Acad. Sci. USA 94, 4330). Briefly, p110D, p110E were immunoprecipitated using 
either an affinity matrix of the phosphopeptide YpVPMLG corresponding to Tyr 751 of the human 
PDGF receptor E coupled to Actigel (Sterogene, CA), p110 isoform-specific antibodies or non-immune 
control antibodies, and subjected to an in vitro kinase reaction using PtdIns(4,5)P2 as a substrate. The 
lipids were resolved by thin-layer chromatography and quantified on a Molecular Imager FX (Bio-Rad).
Supplementary Table 1: List of organs and tissues subjected to histological examination.
adrenal gland
ovary
blood vessels (aorta, vena cava, organ vessels) oviduct
bones pancreas
brain parotid gland
brainstem penis
cerebellum peripheral nerve (sciatic nerve)
coagulating gland pituitary gland
clitoral gland prostate gland
dorsal root ganglia seminal gland
ear skeletal muscle (gastrocnemius, soleus)
epididymis skin
esophagus small intestine (duodenum, jejunum, ileum)
eye spinal cord
fat tissue spleen
gallbladder stomach
harderian gland sublingual gland
heart submandibular gland
kidney testicle
lachrymal gland (exorbital) thymus
large bowel (cecum, colon, rectum) thyroid gland
larynx tongue
liver trachea
lung urinary bladder
lymph nodes uterus
mammary glands vagina
nose vas deferens
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